Akoya BioSciences, Inc. - Common Stock (NQ:AKYA)

1.290 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist

Price and Volume

Volume	0
Open	1.290
Bid (Size)	1.240 (2)
Ask (Size)	1.360 (20)
Prev. Close	1.290
Today's Range	1.290 - 1.290
52wk Range	1.290 - 1.290
Shares Outstanding	49,875,399
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 03, 2025

Via Benzinga

Tuesday's session: gap up and gap down stocks ↗

June 03, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.

Via Chartmill

Performance

More News

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

May 22, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 21, 2025

Via Benzinga

Akoya Biosciences Reports First Quarter 2025 Financial Results

May 12, 2025

From Akoya Biosciences, Inc.

Via GlobeNewswire

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

May 07, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

April 29, 2025

From Quanterix Corporation

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PPBI, SSBK, AKYA on Behalf of Shareholders

April 24, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Pacific Premier Bancorp, Inc. (Nasdaq - PPBI), Southern States Bancshares, Inc. (Nasdaq - SSBK), Akoya Biosciences, Inc. (Nasdaq - AKYA)

April 24, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025

April 24, 2025

From Akoya Biosciences, Inc.

Via GlobeNewswire

Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas

April 24, 2025

From Akoya Biosciences, Inc.

Via GlobeNewswire

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

April 23, 2025

From Akoya Biosciences, Inc.

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders

April 17, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, SLRN, AKYA, SHYF on Behalf of Shareholders

April 07, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities

April 02, 2025

From Akoya Biosciences, Inc.

Via GlobeNewswire

This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

March 26, 2025

Via Benzinga

Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

March 25, 2025

Via Benzinga

This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

March 25, 2025

Via Benzinga

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

March 17, 2025

From Akoya Biosciences, Inc.

Via GlobeNewswire

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

February 05, 2025

From Akoya Biosciences, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 21, 2025

Via Benzinga

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders

January 11, 2025

From Halper Sadeh LLC

Via GlobeNewswire

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

January 10, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Shareholder Alert: Ademi LLP Investigates Whether Akoya Biosciences, Inc. Is Obtaining a Fair Price for Its Public Shareholders

January 10, 2025

From Ademi LLP

Via Business Wire

Frequently Asked Questions

Is Akoya BioSciences, Inc. - Common Stock publicly traded?

Yes, Akoya BioSciences, Inc. - Common Stock is publicly traded.

What exchange does Akoya BioSciences, Inc. - Common Stock trade on?

Akoya BioSciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Akoya BioSciences, Inc. - Common Stock?

The ticker symbol for Akoya BioSciences, Inc. - Common Stock is AKYA on the Nasdaq Stock Market

What is the current price of Akoya BioSciences, Inc. - Common Stock?

The current price of Akoya BioSciences, Inc. - Common Stock is 1.290

When was Akoya BioSciences, Inc. - Common Stock last traded?

The last trade of Akoya BioSciences, Inc. - Common Stock was at 07/07/25 04:00 PM ET

What is the market capitalization of Akoya BioSciences, Inc. - Common Stock?

The market capitalization of Akoya BioSciences, Inc. - Common Stock is 64.34M

How many shares of Akoya BioSciences, Inc. - Common Stock are outstanding?

Akoya BioSciences, Inc. - Common Stock has 64M shares outstanding.